8h
GlobalData on MSNBain Capital buys Mitsubishi Tanabe Pharma for $3.3bnBain Capital said its decision to buy Mitsubishi Tanabe is due to the “strong growth potential” of Japan’s healthcare ...
19h
GlobalData on MSNDr Reddy’s and Shanghai Henlius sign agreement for HLX15Dr Reddy's Laboratories has signed a licence agreement with Shanghai Henlius Biotech to develop and commercialise HLX15.
11h
GlobalData on MSNSanofi increases ownership stake partaking in pharma buyback trendJust days after taking back some of the stake held by L’Oréal, Sanofi has agreed to repurchase its own shares worth €2bn ...
Professor Dame Ijeoma Uchegbu discusses the nanoparticle delivery system behind the non-addictive pain medication Envelta and ...
Dan Rizzo, global head of Veeva Business Consulting, spoke with Pharmaceutical Executive about the state of product launches ...
S&P Global Ratings has revised its outlook on McKesson Corp (NYSE:MCK). to positive from stable, while affirming its 'BBB+' ...
It isn’t just artificial intelligence. Chinese biotech companies are now developing drugs faster and cheaper than their US ...
10h
Zacks.com on MSNHere's Why You Should Retain Glaukos Stock in Your Portfolio NowGKOS continues to benefit from robust product demand and expansion in new markets. A strong development pipeline raises optimism.
Good news for the sector came January 23 when global pharmaceutical giant AstraZeneca plc announced an eye-popping $820 ...
Leading Sheffield-based pharmaceutical company, B. Braun Medical, announces that its HR Director, Helene Ghosh, has been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results